Profile data is unavailable for this security.
About the company
Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
- Revenue in GBP (TTM)11.24bn
- Net income in GBP1.08bn
- Incorporated2021
- Employees24.00k
- LocationHaleon PLCBuilding 5, First Floor, The HeightsBRENTFORD KT13 0NYUnited KingdomGBR
- Phone+44 19 3282 2000
- Websitehttps://www.haleon.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
argenx SE | 980.03m | -235.80m |
UCB SA | 4.49bn | 293.55m |
Bayer AG | 40.77bn | -2.52bn |
HALEON PLC | 11.24bn | 1.08bn |
Lonza Group AG | 5.89bn | 573.01m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 01 Apr 2024 | 163.50m | 1.79% |
Dodge & Coxas of 01 Apr 2024 | 158.25m | 1.73% |
Norges Bank Investment Managementas of 01 Apr 2024 | 148.00m | 1.62% |
First Eagle Investment Management LLCas of 29 Feb 2024 | 117.21m | 1.28% |
BlackRock Fund Advisorsas of 04 Apr 2024 | 107.65m | 1.18% |
MFS International (UK) Ltd.as of 01 Apr 2024 | 98.50m | 1.08% |
GIC Pte Ltd. (Investment Management)as of 01 Apr 2024 | 95.44m | 1.05% |
BlackRock Advisors (UK) Ltd.as of 01 Apr 2024 | 90.98m | 1.00% |
Franklin Mutual Advisers LLCas of 29 Mar 2024 | 85.68m | 0.94% |
Harding Loevner LPas of 28 Mar 2024 | 85.40m | 0.94% |